TGA approves Pfizer booster for adults over 18, six months post-second dose
The Therapeutic Goods Administration has approved the use of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for individuals aged 18 and over, to be administered at least six months after the second dose.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthTGA approves Pfizer booster for adults over 18, six months post-second dose
Sign in or subscribeBrowse free archive reportsThe Therapeutic Goods Administration has approved the use of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for individuals aged 18 and over, to be administered at least six months after the second dose.